Allspring Global Investments’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.7M Buy
582,733
+166,301
+40% +$6.77M 0.03% 520
2025
Q4
$16.9M Buy
416,432
+134,616
+48% +$5.86M 0.03% 582
2025
Q3
$13.3M Buy
281,816
+22,330
+9% +$1.16M 0.02% 631
2025
Q2
$14M Buy
259,486
+1,774
+0.7% +$97.4K 0.02% 609
2025
Q1
$15.3M Buy
257,712
+34,570
+15% +$2.23M 0.03% 599
2024
Q4
$15M Buy
223,142
+68,696
+44% +$4.79M 0.02% 625
2024
Q3
$11.1M Buy
154,446
+66,347
+75% +$4.68M 0.02% 729
2024
Q2
$6.11M Buy
88,099
+87,599
+17,520% +$6.39M 0.01% 895
2024
Q1
$40K Sell
500
-2,449
-83% -$218K ﹤0.01% 1996
2023
Q4
$323K Sell
2,949
-2,774
-48% -$287K ﹤0.01% 1590
2023
Q3
$577K Buy
5,723
+5,386
+1,598% +$619K ﹤0.01% 1495
2023
Q2
$45.8K Buy
337
+81
+32% +$9.89K ﹤0.01% 2313
2023
Q1
$26.6K Sell
256
-1,313
-84% -$127K ﹤0.01% 2452
2022
Q4
$139K Sell
1,569
-34
-2% -$2.82K ﹤0.01% 1948
2022
Q3
$128K Sell
1,603
-2,842
-64% -$268K ﹤0.01% 1976
2022
Q2
$425K Sell
4,445
-16,164
-78% -$1.94M ﹤0.01% 1616
2022
Q1
$3.06M Buy
20,609
+306
+2% +$42.7K ﹤0.01% 1320
2021
Q4
$2.88M Buy
+20,303
New +$2.88M ﹤0.01% 1370

Other funds holding CNMD

Allspring Global Investments's CNMD Position: Q1 2026 in Review

Allspring Global Investments increased its CONMED (CNMD) stake by 40% in Q1 2026, buying an estimated $6.77M and bringing the position to 582,733 shares worth $20.7M. The position accounts for 0.03% of the portfolio, ranked #520.

Allspring Global Investments first reported a position in CNMD in Q4 2021 and has held it in 18 quarters since. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Allspring Global Investments held 582,733 shares of CONMED worth $20.7M as of Q1 2026.
  • Allspring Global Investments bought 166,301 CONMED shares in Q1 2026, an estimated $6.77M.
  • CONMED made up 0.03% of Allspring Global Investments's portfolio in Q1 2026, its #520 holding.
  • Allspring Global Investments first reported a position in CONMED in Q4 2021 and has held it in 18 quarters since.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.